When governments are confronted with a proposal which though soundly based makes them uncomfortable, a common strategy is to declare that it`sends the wrong message'. This, for example, was the initial response to the appeal from public health authorities in the UK to foster needle exchange schemes. Fortunately, the Government did eventually yield to pressure; and, for drug users, the rate of HIV infection is now one of the lowest in Western Europe. In view of this previous episode, it was disappointing to see how quickly the Government rejected the conclusions of the Police Foundation's Independent Inquiry 1 into the Misuse of Drugs Act (MDA). Not only did Mr Blair and his Ministers refuse to accept the analysis: his press secretary even opined that`it would send the worst possible signal if we were to soften our laws in the way being suggested'.
What was the message that so upset the Government, and who sent it? The eighty-one recommendations in the report came from a group who every day deal with the consequences of drug abuse, among them the Director of Intelligence for the National Criminal Intelligence Service, the Deputy Assistant Commissioner of the Metropolitan Police and several noted drug treatment professionalsÐbut no politicians. Their mission was to determine whether the existing British law needed to be revised and whether the laws were working as intended; and their conclusion was that the laws are not working and do need revision.
The recommendations come under six headingsÐclasses and scheduling of drugs; traf®cking offences; non-traf®cking offences (such as altering the penalties for simple possession of heroin); enforcement (including the call for a national computer system to track records of cautions, reprimands and warnings for drug possession, and the creation of à national con®scation agency'); speci®c recommendations about cannabis; and, ®nally, treatment and the law (with a recommendation that there should be a substantial reallocation of resources to treatment, especially for women and children).
Most of the proposalsÐfor example, those intended to update the MDA in the light of modern scienti®c knowl-edgeÐwere utterly uncontroversial. Nevertheless, there was a consternation even over the suggestion that LSD (lysergic acid diethylamide), which is not nearly so dangerous as was once believed, should be reassigned from class A to class B. But what really made politicians see red was the recommendation that cannabis be transferred from class B to class CÐwhich means that possession would no longer be an arrestable offence. At present, cannabis possession accounts for more than 70% of all drug offences, which in 1997 came to a total of 113 000.
Not all the recommendations were so liberal-minded. The panel's endorsement of a national database to track drug users constitutes an attack on the important civil liberty of privacy. The call for asset con®scation also has its critics: if experience in the USA is any guide, this enforcement tool would be misused by police and prosecutors. If a con®scation agency is established, it will need to be coupled with strong protection for the citizen.
The Government could not have been very pleased with the inquiry's conclusions that`the eradication of drug use is not achievable and is not therefore either a realistic or a sensible goal of public policy', and that`possession offences dominate the operation of the law against drugs'. Worse still, the panel could ®nd`no evidence that severe custodial penalties are deterring traf®ckers, and that enforcement, however vigorous, is having a signi®cant effect on supply'; nor were the panelists able to identify any decline in drug purity (high purity goes with high toxicity) during the thirty years of the MDA. Looking at prevalence, they judged that 1 in 300 UK residents is a heroin userÐnot very different from the 1 in 375 in the USA, where drug law is almost equally convoluted and irrational.
The inquiry took great pains to place the matter in its historical context, pointing out the origin of the MDA in international treaties that required nations to establish controls (the Single Convention on Narcotic Drugs 1961 and the Convention on Psychotropic Drugs 1971). But these conventions were not written in stone and individual countries are allowed considerable`wiggle room'. The good news is that international law does permit rational changes in the MDA. The bad news is that such changes are unlikely to have much impact on drug use at a time of massive oversupply 2 . International law does not prevent independent states from selling drugs. In the 1930s Japan was a signatory to several international drug control treaties but ®nanced its occupation of China by selling tons of drugs on the black market 3 . Today, the Taliban ®nances its repressive regime by growing poppies. As long as there are lawless states and peoples at war, drugs will be readily available. How regrettable, then, that the British Government should have rejected the warning from the Police Foundation inquiry that`the law plays a minor part in deterring demand'. Unless and until a way can be found to EDITORIAL 339 JOURNAL OF THE ROYAL SOCIETY OF MEDICINE make people not want drugs, no amount of legal manoeuvring will make the problem go away. But changes in the law could do much to mitigate the damage; even if just the suggestions regarding cannabis were to be implemented, the result would be a massive release of resources to address the other issues.
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